Please note: AABB reserves the right to make updates to this program.
Live Program Date: Wednesday, May 2, 2018 –
Master Program Number: 18EL-335 (see program format numbers below under Registration)
Educational Track: Scientific
Topic: Transfusion Medicine (Hemovigilance)
Intended Audience: Director, Donor Recruitment Staff, Managers/Supervisors, Medical Directors, Nurses, Physicians, Students (MD, MT, SBB)
Teaching Level: Basic to Advanced
Director: James Stubbs, Chair, Division of Transfusion Medicine, Mayo Clinic, Rochester, MN
Moderator: Hany Kamel, MD, VP, Corporate Medical Director, Blood Systems, Inc., Scottsdale, AZ
Presenters: Mindy Goldman, MD, Medical Director, Donor & Clinical Services, Canadian Blood Services, Ontario, CA; Pierre Robillard, MD, Medical Director, Hema-Quebec, Saint-Laurent, QC, CA
After participating in this educational activity, participants should be able to:
- Discuss the physiologic basis of applied muscle tensing and fluid replacement as strategies to mitigate vasovagal reactions.
- Describe interventions that have reduced vasovagal reactions in young blood donors.
- Appreciate the effect on rates of vasovagal reactions of implementing a structured program for water and salted snacks distribution and intake monitoring.
Young donors are at higher risk for vasovagal reactions. Adverse reactions have negative consequences as they relate to donor’s experience and retention. Understanding the physiology facilitates the developments of interventions to mitigate the risk. Several blood collection organizations implemented intervention strategies with success. There will be a discussion of interventions taken to reduce vasovagal reactions in young donors.
| || ||
|Single Viewer: On-Demand||
|Group Viewing: On-Demand||
Dr. Goldman has been interested in blood donor safety for many years. She is a member of the AABB Donor Health and Safety Committee and the AABB Hemovigilance Committee.
Dr. Robillard has been involved in hemovigilance since 1998 both from the recipient and donor aspects. He is a member of the ISBT working parties on hemovigilance and transfusion-transmitted infections and of the AABB PSO advisory working group.